Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Alzamend Neuro, Inc. (ALZN) had Return on Investments of -113.78% for the most recently reported fiscal year, ending 2025-04-30.
| Income Statement Financials | |
-- |
|
$-5.11M |
|
-- |
|
-- |
|
$4.50M |
|
$-4.50M |
|
$-0.02M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.50M |
|
$-4.45M |
|
0.45M |
|
0.45M |
|
$-11.32 |
|
$-11.32 |
|
| Balance Sheet Financials | |
$4.18M |
|
$0.43M |
|
$0.43M |
|
$4.60M |
|
$0.63M |
|
-- |
|
-- |
|
$0.63M |
|
$3.97M |
|
$3.97M |
|
$3.97M |
|
0.78M |
|
| Cash Flow Statement Financials | |
$-6.57M |
|
$-0.30M |
|
$10.44M |
|
$0.38M |
|
$3.95M |
|
$3.57M |
|
$0.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-113.78% |
|
-113.78% |
|
-98.09% |
|
|
Return on Investments |
-113.78% |
$5.10 |
|
$-15.24 |
|
$-14.57 |
|